Hyperion Brookfield Total Return Fund (HTR) 22.69

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hyperion Brookfield Total Return Fund (HTR) 22.69 $HTR

Brookfield Funds' Monthly Distribution Declaration
Marketwired - Fri Jul 08, 4:05PM CDT
NEW YORK, NEW YORK--(Marketwired - Jul 8, 2016) - Brookfield Global Listed Infrastructure Income Fund Inc. (NYSE:INF), Brookfield High Income Fund Inc. (NYSE:HHY), Brookfield Mortgage Opportunity Income Fund Inc. (NYSE:BOI) and Brookfield Total Return Fund Inc. (NYSE:HTR) (each, a "Fund," and collectively, the "Funds" today announced that their Boards of Directors declared their monthly distributions.
HHY: 7.37 (-0.08), BOI: 14.93 (-0.02), INF: 13.48 (-0.12), HTR: 22.69 (-0.13)

Brookfield Investment Management Announces Conference Call for the Proposed Reorganization of Three Brookfield Closed-End Funds and Appointment of Sub-Adviser for Two Brookfield Closed-End Funds
Marketwired - Thu May 26, 4:25PM CDT
NEW YORK, NEW YORK--(Marketwired - May 26, 2016) - Brookfield Investment Management Inc. ("Brookfield" will host a conference call regarding the proposed reorganization of Brookfield Mortgage Opportunity Income Fund Inc. (NYSE:BOI), Brookfield Total Return Fund Inc. (NYSE:HTR) and Brookfield High Income Fund Inc. (NYSE:HHY) (each a "Fund" and together, the "Funds" into Brookfield Real Assets Income Fund Inc., a newly organized Maryland corporation (each, a "Reorganization" and collectively, the "Reorganizations" as well as the proposed appointment of Schroder Investment Management North America Inc. (SIMNA) as sub-adviser for BOI and HTR.
HHY: 7.37 (-0.08), BOI: 14.93 (-0.02), HTR: 22.69 (-0.13)

Brookfield Investment Management Inc. Announces Board Approval of the Reorganization of Three Brookfield Closed-End Funds and the Appointment of a Sub-Adviser for Two Brookfield Closed-End Funds
Marketwire Canada - Mon May 16, 7:45PM CDT
NEW YORK, NEW YORK--(Marketwired - May 16, 2016) - Brookfield Investment Management Inc. ("Brookfield" announced today that
HHY: 7.37 (-0.08), BOI: 14.93 (-0.02), HTR: 22.69 (-0.13)

Brookfield Mortgage Opportunity Income Inc. and Brookfield Total Return Fund Inc. Announce Portfolio Manager Update Call
Marketwired - Tue Jan 19, 4:07PM CST
Brookfield Investment Management Inc. will host a conference call for the Brookfield Mortgage Opportunity Income Fund Inc. (NYSE: BOI) and the Brookfield Total Return Fund Inc. (NYSE: HTR) (the "Funds" on January 29, 2016 at 4:30pm ET. The Funds' portfolio management team will provide an update on the Funds and an update on general market conditions. If you have questions about the Funds that you would like answered on the conference call, please send an e-mail to funds@brookfield.com by 2:00pm ET on January 25, 2016.
BOI: 14.93 (-0.02), HTR: 22.69 (-0.13)

Shares of HTR Down 10.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 18, 12:46PM CST
SmarTrend identified a Downtrend for Helios Total Return Fund (NYSE:HTR) on March 18th, 2015 at $24.06. In approximately 9 months, Helios Total Return Fund has returned 10.79% as of today's recent price of $21.46.
HTR: 22.69 (-0.13)

Downtrend Call Working As Helios Total Return Fund Stock Falls 10.0% (HTR)
Comtex SmarTrend(R) - Fri Dec 11, 11:57AM CST
SmarTrend identified a Downtrend for Helios Total Return Fund (NYSE:HTR) on March 18th, 2015 at $24.06. In approximately 9 months, Helios Total Return Fund has returned 10.00% as of today's recent price of $21.65.
HTR: 22.69 (-0.13)

Helios Total Return Fund Shares Down 10.1% Since SmarTrend's Sell Call (HTR)
Comtex SmarTrend(R) - Fri Dec 04, 9:41AM CST
SmarTrend identified a Downtrend for Helios Total Return Fund (NYSE:HTR) on March 18th, 2015 at $24.06. In approximately 9 months, Helios Total Return Fund has returned 10.08% as of today's recent price of $21.63.
HTR: 22.69 (-0.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading